375 related articles for article (PubMed ID: 9755889)
1. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.
Han HK; Oh DM; Amidon GL
Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889
[TBL] [Abstract][Full Text] [Related]
2. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.
Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL
Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043
[TBL] [Abstract][Full Text] [Related]
3. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.
Anand BS; Patel J; Mitra AK
J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834
[TBL] [Abstract][Full Text] [Related]
4. Effect of ionization on the variable uptake of valacyclovir via the human intestinal peptide transporter (hPepT1) in CHO cells.
Balimane P; Sinko P
Biopharm Drug Dispos; 2000 Jul; 21(5):165-74. PubMed ID: 11180195
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of corneal permeation of L-valyl ester of acyclovir: targeting the oligopeptide transporter on the rabbit cornea.
Anand BS; Mitra AK
Pharm Res; 2002 Aug; 19(8):1194-202. PubMed ID: 12240946
[TBL] [Abstract][Full Text] [Related]
6. Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea.
Anand B; Nashed Y; Mitra A
Curr Eye Res; 2003; 26(3-4):151-63. PubMed ID: 12815543
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of novel dipeptide ester prodrugs of acyclovir after oral administration: intestinal absorption and liver metabolism.
Anand BS; Katragadda S; Mitra AK
J Pharmacol Exp Ther; 2004 Nov; 311(2):659-67. PubMed ID: 15226381
[TBL] [Abstract][Full Text] [Related]
8. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
Gupta D; Varghese Gupta S; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
Mol Pharm; 2013 Feb; 10(2):512-22. PubMed ID: 23244438
[TBL] [Abstract][Full Text] [Related]
9. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line.
Guo A; Hu P; Balimane PV; Leibach FH; Sinko PJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):448-54. PubMed ID: 10087037
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of amino acid ester prodrugs of acyclovir after oral administration: interaction with the transporters on Caco-2 cells.
Katragadda S; Jain R; Kwatra D; Hariharan S; Mitra AK
Int J Pharm; 2008 Oct; 362(1-2):93-101. PubMed ID: 18638532
[TBL] [Abstract][Full Text] [Related]
11. Amino acid ester prodrugs of the anticancer agent gemcitabine: synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transport.
Song X; Lorenzi PL; Landowski CP; Vig BS; Hilfinger JM; Amidon GL
Mol Pharm; 2005; 2(2):157-67. PubMed ID: 15804190
[TBL] [Abstract][Full Text] [Related]
12. Carrier-mediated intestinal absorption of valacyclovir, the L-valyl ester prodrug of acyclovir: 1. Interactions with peptides, organic anions and organic cations in rats.
Sinko PJ; Balimane PV
Biopharm Drug Dispos; 1998 May; 19(4):209-17. PubMed ID: 9604120
[TBL] [Abstract][Full Text] [Related]
13. Delineation of human peptide transporter 1 (hPepT1)-mediated uptake and transport of substrates with varying transporter affinities utilizing stably transfected hPepT1/Madin-Darby canine kidney clones and Caco-2 cells.
Bhardwaj RK; Herrera-Ruiz D; Sinko PJ; Gudmundsson OS; Knipp G
J Pharmacol Exp Ther; 2005 Sep; 314(3):1093-100. PubMed ID: 15901802
[TBL] [Abstract][Full Text] [Related]
14. Dipeptide derivatives of AZT: synthesis, chemical stability, activation in human plasma, hPEPT1 affinity, and antiviral activity.
Santos C; Morais J; Gouveia L; de Clercq E; Pannecouque C; Nielsen CU; Steffansen B; Moreira R; Gomes P
ChemMedChem; 2008 Jun; 3(6):970-8. PubMed ID: 18389514
[TBL] [Abstract][Full Text] [Related]
15. A novel nucleoside prodrug-activating enzyme: substrate specificity of biphenyl hydrolase-like protein.
Kim I; Song X; Vig BS; Mittal S; Shin HC; Lorenzi PJ; Amidon GL
Mol Pharm; 2004; 1(2):117-27. PubMed ID: 15832508
[TBL] [Abstract][Full Text] [Related]
16. Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir.
Balimane PV; Tamai I; Guo A; Nakanishi T; Kitada H; Leibach FH; Tsuji A; Sinko PJ
Biochem Biophys Res Commun; 1998 Sep; 250(2):246-51. PubMed ID: 9753615
[TBL] [Abstract][Full Text] [Related]
17. Ocular penetration of acyclovir and its peptide prodrugs valacyclovir and val-valacyclovir following systemic administration in rabbits: An evaluation using ocular microdialysis and LC-MS.
Dias C; Nashed Y; Atluri H; Mitra A
Curr Eye Res; 2002 Oct; 25(4):243-52. PubMed ID: 12658558
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, metabolism and cellular permeability of enzymatically stable dipeptide prodrugs of acyclovir.
Talluri RS; Samanta SK; Gaudana R; Mitra AK
Int J Pharm; 2008 Sep; 361(1-2):118-24. PubMed ID: 18573320
[TBL] [Abstract][Full Text] [Related]
19. Drug inhibition of Gly-Sar uptake and hPepT1 localization using hPepT1-GFP fusion protein.
Sun D; Landowski CP; Chu X; Wallsten R; Komorowski TE; Fleisher D; Amidon GL
AAPS PharmSci; 2001; 3(1):E2. PubMed ID: 11741253
[TBL] [Abstract][Full Text] [Related]
20. Recognition of L-amino acid ester compounds by rat peptide transporters PEPT1 and PEPT2.
Sawada K; Terada T; Saito H; Hashimoto Y; Inui KI
J Pharmacol Exp Ther; 1999 Nov; 291(2):705-9. PubMed ID: 10525090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
